Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Indiva Reports Fiscal Year 2023 Results Including Record Positive EBITDA and Income (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News PAVmed Inc PAVM

Alternate Symbol(s):  PAVMZ

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PAVM)

Lucid Diagnostics to Participate in Fireside Chat at the 23rd Annual Needham Virtual Healthcare Conference

PR Newswire April 8, 2024

PAVmed Provides Business Update and Fourth Quarter and Full Year 2023 Financial Results

PR Newswire March 26, 2024

Lucid Diagnostics Announces Positive Data from the First Prospective Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

PR Newswire March 21, 2024

PAVmed Launches Incubator to Advance Existing Pipeline Technologies including PortIO, EsoCure and CarpX

PR Newswire March 21, 2024

Lucid Diagnostics Announces Multiple Presentations at the Upcoming Digestive Disease Week (DDW) 2024 Conference

PR Newswire March 20, 2024

PAVmed to Hold a Business Update Conference Call and Webcast on March 27, 2024

PR Newswire March 13, 2024

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 26, 2024

PR Newswire March 12, 2024

Lucid Diagnostics Provides Update Regarding World Trade Center Health Program

PR Newswire February 16, 2024

Lucid Diagnostics Chairman & CEO, Dr. Lishan Aklog, Highlights EsoCheck® Esophageal Cell Collection Device during Congressional Testimony

PR Newswire February 15, 2024
View More News ››

Opinion & Analysis (NDAQ:PAVM)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PAVM)

666

Sixes people!!!
greblokgreblok - June 7, 2021

One Year Later...

One year later and WE ARE COOKING WITH GAS!
greblokgreblok - February 11, 2021

still holding this stock

setting new highs this morning,so glta shareholders.
coolfooldumbguy - February 18, 2020

it's a buy today for me

this morning at $1.95 per share,so glta shareholders.
coolfooldumbguy - February 14, 2020

watching this one for

an entry position,it's doing a device for GERD,which is a common thing,and if this product is successful,this stock will be big,so...
coolfooldumbguy - February 11, 2020

pavmed close to making a big splash

this company looks good i hope they get aproved (fda) then they can start making money
wdf1530 - December 1, 2017
View more Bullboard ››

Mandalay Resources Corp.

Mandalay Resources Corp.

Mandalay Resources Corporation is a Canada-based natural resource company with producing assets in Australia (Costerfield ...
View More »